# FDA Inspection 1084681 - Blythe Enterprises Inc - March 14, 2019

Source: https://www.globalkeysolutions.net/records/fda_inspections/blythe-enterprises-inc/05f88923-3755-43dd-8c22-15be4d08b03b
Source feed: FDA_Inspections

> FDA Inspection 1084681 for Blythe Enterprises Inc on March 14, 2019. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1084681
- Company Name: Blythe Enterprises Inc
- Inspection Date: 2019-03-14
- Classification: No Action Indicated (NAI)
- Project Area: Human Cellular, Tissue, and Gene Therapies
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 991814 - 2016-11-07](https://www.globalkeysolutions.net/records/fda_inspections/blythe-enterprises-inc/80ce8c18-0070-48b1-8031-a096e7cb06bf)
- [FDA Inspection 905169 - 2014-11-19](https://www.globalkeysolutions.net/records/fda_inspections/blythe-enterprises-inc/f8262158-8de0-4b5b-9b01-9f99231d11c8)

Company: https://www.globalkeysolutions.net/companies/blythe-enterprises-inc/9f30f6f7-cf5e-4abd-b4ca-954fbccce090

Office: https://www.globalkeysolutions.net/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d